Youth

Come on your own, with friends, or bring the whole family to the museum for a special week of programming.

Heidi Greulich and Matthew Meyerson will describe the 20-year history of sevabertinib, a new lung cancer drug that blocks both EGFR and the related HER2 protein.

Can we mimic the extreme resilience of human tissues? Can we grow alternatives to traditional plastics? Can we engineer a bio-inspired future?